A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 197

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 197
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 271
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3165
Function: getPubMedXML

File: /var/www/html/application/controllers/Detail.php
Line: 597
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 511
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 317
Function: require_once

Correction to: Association between plasma interleukin-33 level and acute exacerbation of chronic obstructive pulmonary disease. | LitMetric
Browse Categories

Correction to: Association between plasma interleukin-33 level and acute exacerbation of chronic obstructive pulmonary disease.

Hyonsoo Joo , Seoung Ju Park , Kyung Hoon Min , Chin Kook Rhee

BMC Pulm Med

Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpodaero, Seochogu, Seoul, 06591, Republic of Korea.

Published: October 2021

Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

 Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556922PMC
http://dx.doi.org/10.1186/s12890-021-01703-3DOI Listing

Publication Analysis

Top Keywords

correction association
4
association plasma
4
plasma interleukin-33
4
interleukin-33 level
4
level acute
4
acute exacerbation
4
exacerbation chronic
4
chronic obstructive
4
obstructive pulmonary
4
pulmonary disease
4

Similar Publications

Privacy Policy Site Map

© LitMetric 2025. All rights reserved.